Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study

Autor: van Oers, Marinus H J, Kuliczkowski, Kazimierz, Smolej, Lukáš, Petrini, Mario, Offner, Fritz, Grosicki, Sebastian, Levin, Mark-David, Gupta, Ira, Phillips, Jennifer, Williams, Vanessa, Manson, Stephanie, Lisby, Steen, Geisler, Christian
Zdroj: In The Lancet Oncology October 2015 16(13):1370-1379
Databáze: ScienceDirect